TrialAlzheimer's research & therapy2018

Pharmacodynamics of atabecestat (JNJ-54861911), an oral BACE1 inhibitor in patients with early Alzheimer's disease: randomized, double-blind, placebo-controlled study.

Maarten Timmers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.